Stroke and Systemic Embolism Prevention in Patients with Atrial Fibrillation in Belgium: Comparative Cost Effectiveness of New Oral Anticoagulants and Warfarin
Conclusions
Amongst NOACs, apixaban may be the most economically efficient alternative to warfarin in NVAF patients who are suitable for VKA treatment and eligible for stroke prevention in Belgium.
Source: Clinical Drug Investigation - Category: Drugs & Pharmacology Source Type: research
More News: Atrial Fibrillation | Belgium Health | Bleeding | Cardiology | Cardiovascular | Coumadin | Drugs & Pharmacology | Heart | Heart Attack | Hemorrhagic Stroke | Hospital Management | Ischemic Stroke | Pradaxa | Stroke | Study | Vitamins | Warfarin